{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T09:47:55Z","timestamp":1770716875952,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T00:00:00Z","timestamp":1531094400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1038\/s41391-018-0056-7","type":"journal-article","created":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T13:41:27Z","timestamp":1531143687000},"page":"524-532","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Cost and efficacy comparison of five prostate biopsy modalities: a platform for integrating cost into novel-platform comparative research"],"prefix":"10.1038","volume":"21","author":[{"given":"Muammer","family":"Altok","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bumyang","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bina B.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Chen Tina","family":"Shih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen E.","family":"McRae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian F.","family":"Chapin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis L.","family":"Pisters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtis A.","family":"Pettaway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeri","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huseyin C.","family":"Demirel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,9]]},"reference":[{"key":"56_CR1","first-page":"15","volume":"6","author":"W Aubry","year":"2013","unstructured":"Aubry W, Lieberthal R, Willis A, Bagley G, Willis SM, Layton A. Budget impact model: epigenetic assay can help avoid unnecessary repeated prostate biopsies and reduce healthcare spending. Am Health Drug Benefits. 2013;6:15\u201324.","journal-title":"Am Health Drug Benefits"},{"key":"56_CR2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.eururo.2013.09.046","volume":"65","author":"A Heidenreich","year":"2014","unstructured":"Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, et al. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol. 2014;65:124\u201337.","journal-title":"Eur Urol"},{"key":"56_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ucl.2014.01.011","volume":"41","author":"MA Bjurlin","year":"2014","unstructured":"Bjurlin MA, Wysock JS, Taneja SS. Optimization of prostate biopsy: review of technique and complications. Urol Clin North Am. 2014;41:299\u2013313.","journal-title":"Urol Clin North Am"},{"key":"56_CR4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/iju.12595","volume":"22","author":"J Wang","year":"2015","unstructured":"Wang J, Wang L, Du Y, He D, Chen X, Li L, et al. Addition of intrarectal local analgesia to periprostatic nerve block improves pain control for transrectal ultrasonography-guided prostate biopsy: a systematic review and meta-analysis. Int J Urol. 2015;22:62\u20138.","journal-title":"Int J Urol"},{"key":"56_CR5","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/jama.2014.17942","volume":"313","author":"MM Siddiqui","year":"2015","unstructured":"Siddiqui MM, Rais-Bahrami S, Turkbey B, George AK, Rothwax J, Shakir N, et al. Comparison of MR\/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA. 2015;313:390\u20137.","journal-title":"JAMA"},{"key":"56_CR6","first-page":"11","volume":"104","author":"MJ Roberts","year":"2017","unstructured":"Roberts MJ, Bennett HY, Harris PN, Holmes M, Grummet J, Naber K, et al. Prostate biopsy-related infection: a systematic review of risk factors, prevention strategies, and management approaches. Urology. 2017;104:11\u201321.","journal-title":"JAMA"},{"key":"56_CR7","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.eururo.2014.10.033","volume":"67","author":"EHJ Hamoen","year":"2015","unstructured":"Hamoen EHJ, de Rooij M, Witjes JA, Barentsz JO, Rovers MM. Use of the Prostate Imaging Reporting and Data System (PI-RADS) for prostate cancer detection with multiparametric magnetic resonance imaging: a diagnostic meta-analysis. Eur Urol. 2015;67:1112\u201321.","journal-title":"Eur Urol"},{"key":"56_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.clgc.2017.10.013","volume":"16","author":"DD Yang","year":"2018","unstructured":"Yang DD, Mahal BA, Muralidhar V, Vastola ME, Boldbaatar N, Labe SA, et al. Pathologic outcomes of Gleason 6 favorable intermediate-risk prostate cancer treated with radical prostatectomy: implications for active surveillance. Clin Genitourin Cancer. 2018;16:226\u201334.","journal-title":"Clin Genitourin Cancer"},{"key":"56_CR9","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1097\/01.ju.0000181212.51025.06","volume":"174","author":"R Autorino","year":"2005","unstructured":"Autorino R, De Sio M, Di Lorenzo G, Damiano R, Perdon\u00e0 S, Cindolo L, et al. How to decrease pain during transrectal ultrasound guided prostate biopsy: a look at the literature. J Urol. 2005;174:2091\u20137.","journal-title":"J Urol"},{"key":"56_CR10","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/aja.2011.16","volume":"13","author":"SG Kang","year":"2011","unstructured":"Kang SG, Tae BS, Min SH, Ko YH, Kang SH, Lee JG, et al. Efficacy and cost analysis of transrectal ultrasound-guided prostate biopsy under monitored anesthesia. Asian J Androl. 2011;13:724\u20137.","journal-title":"Asian J Androl"},{"key":"56_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ejrad.2005.08.001","volume":"57","author":"AT Turgut","year":"2006","unstructured":"Turgut AT, Ergun E, Ko\u015far U, Ko\u015far P, Ozcan A. Sedation as an alternative method to lessen patient discomfort due to transrectal ultrasonography-guided prostate biopsy. Eur J Radiol. 2006;57:148\u201353.","journal-title":"Eur J Radiol"},{"key":"56_CR12","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1046\/j.1464-410x.2001.02221.x","volume":"87","author":"JL Peters","year":"2001","unstructured":"Peters JL, Thompson AC, McNicholas TA, Hines JE, Hanbury DC, Boustead GB. Increased patient satisfaction from transrectal ultrasonography and biopsy under sedation. BJU Int. 2001;87:827\u201330.","journal-title":"BJU Int"},{"key":"56_CR13","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.urolonc.2012.01.001","volume":"31","author":"B Gershman","year":"2013","unstructured":"Gershman B, Zietman AL, Feldman AS, McDougal WS. Transperineal template-guided prostate biopsy for patients with persistently elevated PSA and multiple prior negative biopsies. Urol Oncol. 2013;31:1093\u20137.","journal-title":"Urol Oncol"},{"key":"56_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.eururo.2012.06.004","volume":"63","author":"CM Moore","year":"2013","unstructured":"Moore CM, Robertson NL, Arsanious N, Middleton T, Villers A, Klotz L, et al. Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol. 2013;63:125\u201340.","journal-title":"Eur Urol"},{"key":"56_CR15","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.urolonc.2011.02.014","volume":"29","author":"S Natarajan","year":"2011","unstructured":"Natarajan S, Marks LS, Margolis DJ, Huang J, Macairan ML, Lieu P, et al. Clinical application of a 3D ultrasound-guided prostate biopsy system. Urol Oncol. 2011;29:334\u201342.","journal-title":"Urol Oncol"},{"key":"56_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s11934-013-0323-z","volume":"14","author":"CG Overduin","year":"2013","unstructured":"Overduin CG, F\u00fctterer JJ, Barentsz JO. MRI-guided biopsy for prostate cancer detection: a systematic review of current clinical results. Curr Urol Rep. 2013;14:209\u201313.","journal-title":"Curr Urol Rep"},{"key":"56_CR17","first-page":"A100","volume":"4","author":"DU Ekwueme","year":"2007","unstructured":"Ekwueme DU, Stroud LA, Chen Y. Cost analysis of screening for, diagnosing, and staging prostate cancer based on a systematic review of published studies. Prev Chronic Dis. 2007;4:A100.","journal-title":"Prev Chronic Dis"},{"key":"56_CR18","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.eururo.2013.12.012","volume":"66","author":"M Rooij de","year":"2014","unstructured":"de Rooij M, Crienen S, Witjes JA, Barentsz JO, Rovers MM, Grutters JP. Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective. Eur Urol. 2014;66:430\u20136.","journal-title":"Eur Urol"},{"key":"56_CR19","doi-asserted-by":"publisher","first-page":"266.e9","DOI":"10.1016\/j.urolonc.2015.03.007","volume":"33","author":"Y Lotan","year":"2015","unstructured":"Lotan Y, Haddad AQ, Costa DN, Pedrosa I, Rofsky NM, Roehrborn CG. Decision analysis model comparing cost of multiparametric magnetic resonance imaging vs. repeat biopsy for detection of prostate cancer in men with prior negative findings on biopsy. Urol Oncol. 2015;33:266.e9\u201316.","journal-title":"Urol Oncol"},{"key":"56_CR20","doi-asserted-by":"publisher","first-page":"119.e1","DOI":"10.1016\/j.urolonc.2015.09.010","volume":"34","author":"Y Cerantola","year":"2016","unstructured":"Cerantola Y, Dragomir A, Tanguay S, Bladou F, Aprikian A, Kassouf W. Cost-effectiveness of multiparametric magnetic resonance imaging and targeted biopsy in diagnosing prostate cancer. Urol Oncol. 2016;34:119.e1\u20139.","journal-title":"Urol Oncol"},{"key":"56_CR21","first-page":"1","volume":"22","author":"W Venderink","year":"2017","unstructured":"Venderink W, Govers TM, de Rooij M, F\u00fctterer JJ, Sedelaar JP. Cost-effectiveness comparison of imaging-guided prostate biopsy techniques: systematic transrectal ultrasound, direct in-bore MRI, and image fusion. AJR Am J Roentgenol. 2017;22:1\u20136.","journal-title":"AJR Am J Roentgenol"},{"key":"56_CR22","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/bju.13193","volume":"118","author":"JW Davis","year":"2016","unstructured":"Davis JW, Ward JF, Pettaway CA, Wang X, Kuban D, Frank SJ, et al. Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance. BJU Int. 2016;118:68\u201376.","journal-title":"BJU Int"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41391-018-0056-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41391-018-0056-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41391-018-0056-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:33:16Z","timestamp":1684618396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41391-018-0056-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,9]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["56"],"URL":"https:\/\/doi.org\/10.1038\/s41391-018-0056-7","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,9]]},"assertion":[{"value":"18 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Davis: education grant from Intuitive Surgical and research support from Janssen, Genome DX. The remaining authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}